Finance

Lists
ELAN:NYSE
Elanco Animal Health Inc
23,55 USD
+0,04%
(+0,0100) 1D
23,55 USD
0,00% (0,00)
After hours
Closed: 16-окт., 16:00:07 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ELAN...
Open
23,87 USD
High
24,11 USD
Low
23,41 USD
Mkt. cap
11,77 млд
Avg. vol.
5,34 млн
Volume
5,17 млн
52-wk high
27,98 USD
52-wk low
19,40 USD
EPS
-0,42 USD
Beta
1,71
Shares outstanding
499,62 млн
No. of employees
10 миң
Open
23,87 USD
High
24,11 USD
Low
23,41 USD
Mkt. cap
11,77 млд
Avg. vol.
5,34 млн
Volume
5,17 млн
52-wk high
27,98 USD
52-wk low
19,40 USD
EPS
-0,42 USD
Beta
1,71
Shares outstanding
499,62 млн
No. of employees
10 миң
News stories
From web sources and news partners
Profile
Elanco Animal Health Incorporated is an American pharmaceutical company which produces medicines and vaccinations for pets and livestock. Until 2019, the company was a subsidiary of Eli Lilly and Company, before being divested. It is the third-largest animal health company in the world. Wikipedia
About Elanco Animal Health Inc
CEOJeffrey N. Simmons
Employees9,65 миң
Founded1954
HeadquartersИндианаполис, Индиана, Америка Кошмо Штаттары
SectorPharmaceutical industry
Websiteelanco.com
Analyst ratings
Based on 12 analysts giving stock ratings to ELAN in the past 3 months
Strong buy
Buy
11
Hold
1
Sell
0
12-month forecast
Based on 12 Wall Street analysts offering 12 month price targets for ELAN in the last 3 months.
Highest
Current 23,55 USD
34,00 USD (+44,37%)
Average
31,60 USD (+34,18%)
Lowest
26,00 USD (+10,40%)
Analyst
Recommendation
Action
Price target
Projected
Date
Chris Schott
J.P. Morgan
Buy
Maintained
33,00 USD
+40,1%
10/16/2026
Daniel Clark
Leerink Partners
Buy
Reiterated
34,00 USD
+44,4%
10/01/2026
Jonathan Block
Stifel Nicolaus
Buy
Reiterated
-
-
09/18/2026
Steve Scala
TD Cowen
Buy
Reiterated
32,00 USD
+35,9%
08/25/2026
Glen Santangelo
Barclays
Buy
Maintained
30,00 USD
+27,4%
08/21/2026
Michael Ryskin
Bank of America Securities
Buy
Maintained
34,00 USD
+44,4%
08/12/2026
Brandon Vazquez
William Blair
Buy
Maintained
-
-
08/12/2026
Erin Wright
Morgan Stanley
Hold
Reiterated
26,00 USD
+10,4%
08/10/2026
David Westenberg
Piper Sandler
Buy
Maintained
30,00 USD
+27,4%
08/10/2026
Andrea Alfonso
UBS
Buy
Maintained
33,00 USD
+40,1%
08/06/2026
Daniel Grosslight
Citi
Buy
Maintained
34,00 USD
+44,4%
08/06/2026
Scott Schoenhaus
KeyBanc
Buy
Maintained
30,00 USD
+27,4%
08/06/2026
Jasper Hellweg
Argus Research
Buy
Maintained
-
-
06/23/2026
Umer Raffat
Evercore ISI
Buy
Maintained
-
-
05/11/2026
Unknown Analyst
Jefferies
Buy
Maintained
30,00 USD
+27,4%
02/25/2026
Last report
2026-ж., 5-авг.
Fiscal period
Q2 2026
0,34 USD / 0,27 USD
+26,46%beat
Revenue / Est. (USD)
1,37 млд / 1,31 млд
+4,16%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
1,14 млд
1,14 млд
1,37 млд
1,37 млд
Cost of goods sold
530,00 млн
555,00 млн
586,00 млн
570,00 млн
Cost of revenue
530,00 млн
555,00 млн
586,00 млн
570,00 млн
Research and development expenses
89,00 млн
93,00 млн
97,00 млн
92,00 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
351,00 млн
331,00 млн
381,00 млн
449,00 млн
Operating expense
580,00 млн
563,00 млн
616,00 млн
680,00 млн
Total operating expenses
1,11 млд
1,12 млд
1,20 млд
1,25 млд
Operating income
27,00 млн
26,00 млн
169,00 млн
118,00 млн
Other non operating income
2,00 млн
-15,00 млн
-8,00 млн
-11,00 млн
EBT including unusual items
-50,00 млн
-259,00 млн
87,00 млн
56,00 млн
EBT excluding unusual items
-25,00 млн
-37,00 млн
103,00 млн
65,00 млн
Income tax expense
-16,00 млн
17,00 млн
30,00 млн
2,00 млн
Effective tax rate
32,00%
-6,56%
34,48%
3,57%
Other operating expenses
-
-
-
-
Net income
-34,00 млн
-276,00 млн
57,00 млн
54,00 млн
Net profit margin
-2,99%
-24,13%
4,16%
3,95%
Earnings per share
0,19
0,13
0,40
0,34
Interest and investment income
-
45,00 млн
-
-
Interest expense
-52,00 млн
-105,00 млн
-57,00 млн
-59,00 млн
Net interest expenses
-52,00 млн
-60,00 млн
-57,00 млн
-59,00 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
195,00 млн
194,00 млн
335,00 млн
283,00 млн
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google колдонмолору